Neoplasms, Colorectal Completed Phase 2 Trials for Selumetinib (DB11689)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01333475MK-2206 and AZD6244 in Patients With Advanced Colorectal CarcinomaTreatment